ONC Evaluation Details
Each submitted Data Element has been evaluated based on the following criteria. The overall Level classification is a composite of the maturity based on these individual criteria. This information can be used to identify areas that require additional work to raise the overall classification level and consideration for inclusion in future versions of USCDI
|
Criterion #1 Maturity - Current Standards |
Level 2
- Data element is represented by a terminology standard or SDO-balloted technical specification or implementation guide.
|
Criterion #2 Maturity - Current Use
|
Level 2
- Data element is captured, stored, or accessed in multiple production EHRs or other HIT modules from more than one developer.
|
Criterion #3 Maturity - Current Exchange |
Level 2
- Data element is electronically exchanged between more than two production EHRs or other HIT modules of different developers using available interoperability standards.
|
Criterion #4 Use Case(s) - Breadth of Applicability |
Level 0
- Use cases apply to a limited number of care settings or specialties, or data element represents a specialization of other, more general data elements.
|
| Evaluation Comment |
This data element represents a specific type of existing USCDI data element Performance Time in the Procedures data class. |
Submitted by CDC_DSMH_WG on
CDC comments for draft USCDI v8
CDC recommends the inclusion of vaccine administration date in draft USCDI v8. Approximately 70% of oropharyngeal cancers in the United States are thought to be caused by HPV. However, it is not yet clear whether HPV infection alone is enough to cause oropharyngeal cancer or whether other factors interact with HPV and contribute to the development of these cancers. The HPV vaccine protects against the types of HPV that can cause oropharyngeal cancers, suggesting that vaccination may also help prevent these cancers. HPV vaccination policies vary widely, and there are also considerable differences in the barriers that affect the implementation and sustainability of vaccination programs. The United States continues to struggle to achieve its HPV vaccination goals. Surveillance of HPV vaccination, along with other risk factors, can help establish associations and identify populations that may be at greater risk. This information can also help guide clinical decision-making, guidelines, and interventions aimed at increasing HPV vaccine acceptance and reducing the prevalence and incidence of HPV-associated oropharyngeal cancers.
Standardized collection and exchange of this data element would strengthen surveillance of HPV vaccination and associated risk factors. Inclusion in USCDI would improve data consistency and interoperability across healthcare and public health systems, helping identify at-risk populations, inform clinical and public health interventions, increase vaccination acceptance, and reduce HPV-associated oropharyngeal cancer prevalence and incidence.
U.S. Core details:
It says "Occurence Date time" i.e., Vaccine administration date must be supported.
https://build.fhir.org/ig/HL7/US-Core/StructureDefinition-us-core-immunization.html
https://build.fhir.org/ig/HL7/US-Core/StructureDefinition-us-core-immunization-definitions.html#Immunization.occurrence[x] • US Core Immunization Profile: https://build.fhir.org/ig/HL7/US-Core/StructureDefinition-us-core-immunization.html
• US Core Must Support/Mandatory definitions: https://build.fhir.org/ig/HL7/US-Core/must-support.html
• HL7 v2.5.1 Implementation Guide for Immunization Messaging (Release 1.5): https://www.cdc.gov/vaccines/programs/iis/technical-guidance/downloads/hl7guide-1-5-2014-11.pdf